← Back to all trials
Recruiting
NCT06642597
STarting incrEmental Prescription of Peritoneal Dialysis
Conditions: Peritoneal Dialysis (PD), Kidney Failure
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 224
Sponsor: The University of Queensland
Location: Blacktown Blacktown New South Wales
Summary
Kidney failure is fatal without dialysis. Peritoneal dialysis (PD) completed at home offers greater flexibility and autonomy for patients . However, PD is often prescribed for 24 hours/day, 7 days/week for every patient starting dialysis. This practice is not evidence-informed, may be unnecessary and potentially harmful. The STEP-PD trial aims to determine the optimal approach to commencing patients on PD through starting at low dose PD and incrementing over time.
Eligibility Criteria
Inclusion Criteria:
* adults (≥18 years) commencing PD as their first dialysis therapy (and been on dialysis for \
Source: ClinicalTrials.gov (NCT06642597). StuddyBuddy aggregates publicly available trial information.
